fbpx
Oncolife - Δρ. Ιωάννης Μούντζιος, Ογκολόγος - Παθολόγος
Oncolife - Κέντρο Ολιστικής Φροντίδας Ογκολογικού Ασθενή | Αθήνα - Κώς | 210 74.70.960 - 6983 51.99.89
Ραντεβού

ONCOLIFE

Δημοσιεύσεις

Κέντρο Ολιστικής Φροντίδας Ογκολογικού Ασθενή

 

Παρακάτω μπορείτε να δείτε δημοσιεύσεις του Ιατρού Ι. Μούντζιου σε ιατρικά περιοδικά.

ΧΡΟΝΟΛΟΓΙΑΤΙΤΛΟΣΣΥΓΓΡΑΦΕΙΣΔΗΜΟΣΙΕΥΣΗ
2018Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer.Gkolfinopoulos S, Mountzios G.Ann Transl Med. 2018 Apr
2018Making progress in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer by surpassing resistance: third-generation EGFR tyrosine kinase inhibitors (EGFR-TKIs).Mountzios G.Ann Transl Med. 2018 Apr;
2018Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?Baxevanos P, Mountzios G.Ann Transl Med. 2018 Apr
2018The emerging treatment landscape of advanced non-small cell lung cancer.Economopoulou P, Mountzios G.Ann Transl Med. 2018 Apr
2018Lung cancer: biology and technology foster therapeutic innovation.Mountzios G.Ann Transl Med. 2018 Apr
2018Adjuvant bevacizumab for resected non-small cell lung cancer: the end of an era?Mountzios G.Transl Lung Cancer Res. 2018 Apr
2018The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.Papadimitriou M, Mountzios G, Papadimitriou CA.Cancer Treat Rev. 2018 Jun
2017Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis.De Mello RA, Escriu C, Castelo-Branco P, Cabral PL, Mountzios G, Lopes GL, Madureira P.Oncotarget. 2017 Dec
2017Dr. Giannis Mountzios: immunotherapy, an "earthquake" in the treatment of advanced lung cancer.Ling N.Transl Lung Cancer Res. 2017 Dec
2017The care of adolescents and young adults with cancer: results of the ESMO/SIOPE survey.Saloustros E, Stark DP, Michailidou K, Mountzios G, Brugieres L, Peccatori FA, Jezdic S, Essiaf S, Douillard JY, Bielack S.ESMO Open. 2017 Sep
2017Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.Banerjee S, Califano R, Corral J, de Azambuja E, De Mattos-Arruda L, Guarneri V, Hutka M, Jordan K, Martinelli E, Mountzios G, Ozturk MA, Petrova M, Postel-Vinay S, Preusser M, Qvortrup C, Volkov MNM, Tabernero J, Olmos D, Strijbos MH.Ann Oncol. 2017 Jul
2016Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Economopoulou P, Mountzios G.Transl Lung Cancer Res. 2016 Dec
2016ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y.ESMO Open. 2016 Sep
2016Future perspectives in cancer immunotherapy.Tsiatas M, Mountzios G, Curigliano G.Ann Transl Med. 2016 Jul
2016Immunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting.Mountzios G, Linardou H, Kosmidis P.Ann Transl Med. 2016 Jul
2016A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker.Aguiar PN Jr, Santoro IL, Tadokoro H, de Lima Lopes G, Filardi BA, Oliveira P, Castelo-Branco P, Mountzios G, de Mello RA.Immunotherapy. 2016 Sep
2016ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G; ESMO/ASCO Global Curriculum Working Group.Ann Oncol. 2016 Aug
2016Therapies in the pipeline for small-cell lung cancer.Romanidou O, Imbimbo M, Mountzios G, Abidin A, Morgillo F, Califano R.Br Med Bull. 2016 Sep
2016Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?Califano R, Romanidou O, Mountzios G, Landi L, Cappuzzo F, Blackhall F.Drugs. 2016 May
2016Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.Metro G, Ricciuti B, Chiari R, Baretti M, Falcinelli L, Giannarelli D, Sidoni A, Mountzios G, Crinò L, Bellezza G, Rebonato A, Ferolla P, Toschi L.Lung Cancer. 2016 May
2016The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis.Aguiar PN Jr, Santoro IL, Tadokoro H, de Lima Lopes G, Filardi BA, Oliveira P, Mountzios G, de Mello RA.Immunotherapy. 2016
2016Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.Mountzios G, Aravantinos G, Alexopoulou Z, Timotheadou E, Matsiakou F, Christodoulou C, Laschos K, Galani E, Koutras A, Bafaloukos D, Linardou H, Pectasides D, Varthalitis I, Papakostas P, Kalofonos HP, Fountzilas G.Mol Clin Oncol. 2016 Feb
2016Novel therapies for advanced squamous cell carcinoma of the lung.Koutsoukos K, Mountzios G.Future Oncol. 2016 Mar
2016Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms.Monteiro ID, Califano R, Mountzios G, de Mello RA.Future Oncol. 2016 Feb
2016Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated project.Stark D, Bielack S, Brugieres L, Dirksen U, Duarte X, Dunn S, Erdelyi DJ, Grew T, Hjorth L, Jazbec J, Kabickova E, Konsoulova A, Kowalczyk JR, Lassaletta A, Laurence V, Lewis I, Monrabal A, Morgan S, Mountzios G, Olsen PR, Renard M, Saeter G, van der Graaf WT, Ferrari A.Eur J Cancer Care (Engl). 2016 May
2015Cancer of Unknown Primary origin in the genomic era: Elucidating the dark box of cancer.Economopoulou P, Mountzios G, Pavlidis N, Pentheroudakis G.Cancer Treat Rev. 2015 Jul
2015Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents.Califano R, Morgillo F, De Mello RA, Mountzios G.Ann Transl Med. 2015 Apr
2015Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.Califano R, Abidin A, Tariq NU, Economopoulou P, Metro G, Mountzios G.Cancer Treat Rev. 2015 May
2015Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy.Mountzios G.World J Clin Oncol. 2015 Feb
2014Immunotherapy and lung cancer: current developments and novel targeted therapies.Domingues D, Turner A, Silva MD, Marques DS, Mellidez JC, Wannesson L, Mountzios G, de Mello RA.Immunotherapy.
2014Do elderly patients with non-small cell lung cancer get the best out of recent advances in first-line treatment? A comparative study in two tertiary cancer centers in Greece.Bakogeorgos M, Mountzios G, Bournakis E, Economopoulou P, Kotsantis G, Fytrakis N, Kouvatseas G, Dimopoulos MA, Kentepozidis N.J Geriatr Oncol. 2015 Mar
2014The case of the missed chest radiograph: bilateral mammary gland metastases mimicking multifocal primary breast cancer as the initial manifestation of non-small-cell lung cancer.Mountzios G, Gyftopoulos A, Vlotinou E, Kentepozidis N.J Thorac Oncol. 2014 Nov
2014The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.Mountzios G, Rampias T, Psyrri A.Ann Oncol. 2014 Oct
2014Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.Mountzios G, Aivazi D, Kostopoulos I, Kourea HP, Kouvatseas G, Timotheadou E, Zebekakis P, Efstratiou I, Gogas H, Vamvouka C, Chrisafi S, Stofas A, Pentheroudakis G, Koutras A, Galani E, Bafaloukos D, Fountzilas G.PLoS One. 2014 Mar
2014Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC.Champiat S, Ileana E, Giaccone G, Besse B, Mountzios G, Eggermont A, Soria JC.J Thorac Oncol. 2014 Feb
2014Bevacizumab and micrometastases: revisiting the preclinical and clinical rollercoaster.Mountzios G, Pentheroudakis G, Carmeliet P.Pharmacol Ther. 2014 Feb
2013Chemotherapy compliance, tolerance and efficacy in elderly and non-elderly patients with metastatic colorectal cancer: a single institution comparative study.Bakogeorgos M, Mountzios G, Kotsantis G, Economopoulou P, Fytrakis N, Kentepozidis N.J BUON. 2013 Jul-Sep
2013Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.Mountzios G, Soultati A, Pectasides D, Dimopoulos MA, Papadimitriou CA.Obstet Gynecol Int.
2013Adrenal incidentalomas in cancer patients are not always "innocent": a case report and review of the literature.Economopoulou P, Mountzios G, Kotsantis I, Bakogeorgos M, Ramfidis V, Kapiris I, Patsouris E, Kentepozidis N.Case Rep Med.
2013Developments in the systemic treatment of metastatic cervical cancer.Mountzios G, Soultati A, Pectasides D, Pectasides E, Dimopoulos MA, Papadimitriou CA.Cancer Treat Rev. 2013 Aug
2013«Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer» Mountzios G, Kostopoulos I, Kotoula V, Sfakianaki I, Fountzilas E, Markou K, Karasmanis I, Leva S, Angouridakis N, Vlachtsis K, Nikolaou A, Konstantinidis I, Fountzilas G. PLoS One. 2013;8(1):e54048. doi: 10.1371/journal.pone.0054048. Epub 2013 Jan 24.
2012«Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications» Soultati A, Mountzios G, Avgerinou C, Papaxoinis G, Pectasides D, Dimopoulos MA, Papadimitriou C. Cancer Treat Rev. 2012 Aug;38(5):473-83.
2012«Array-based pharmacogenomics of molecular-targeted therapies in oncology» Sanoudou D, Mountzios G, Arvanitis DA, Pectasides D. Pharmacogenomics J. 2012 Jun;12(3):185-96.
2012«Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group» Mountzios G, Emmanouilidis C, Vardakis N, Kontopodis E, Hatzidaki D, Popis E, Karachaliou N, Kotsakis A, Agelidou M, Georgoulias V. Lung Cancer. 2012 Jul;77(1):146-50.
2012«Bevacizumab in ovarian cancer.» Mountzios G, Pentheroudakis G. N Engl J Med. 2012 Mar 29;366(13):1257; author reply 1258.
2012«Developments in the systemic treatment of metastatic cervical cancer» Mountzios G, Soultati A, Pectasides D, Pectasides E, Dimopoulos MA, Papadimitriou CA.Cancer Treat Rev. 2012 Jun 22. [Epub ahead of print]
2011«Developments in the systemic treatment of endometrial cancer» Giannis Mountzios, Dimitrios Pectasides, Eftichia Kafantari, Eirini Pectasides, George Bozas, Meletios-A. Dimopoulos and Christos A. Papadimitriou Crit Rev Oncol Hematol. 2011 Sep;79(3):278-92
2011«Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data» Mountzios G, Ramfidis V, Terpos E, Syrigos KN. Clin Lung Cancer. 2011 Nov;12(6):341-9.
2011«A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer» Mountzios G, Syrigos KN. Drug Saf. 2011 Mar 1;34(3):175-86.
2011«Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer»Mountzios I, Bournakis E, Efstathiou E, Varkaris A, Wen S, Chrisofos M, Deliveliotis C, Alamanis C, Anastasiou I, Constantinides C, Karadimou A, Tsiatas M, Papadimitriou C, Bamias A, Dimopoulos MA. Urology. 2011 Mar;77(3):682-7.
2011«All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer»Linardou H, Briasoulis E, Dahabreh IJ, Mountzios G, Papadimitriou C, Papadopoulos S, Bafaloukos D, Kosmidis P, Murray S.Cancer Treat Rev. 2011 May;37(3):221-33
2010«Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrogen-mediated vasodilatation» Vassilakopoulou M, Mountzios G, Papamechael C, Protogerou A D, Aznaouridis K, Katsichti P, Venetsanou K, Dimopoulos M-A, Ikonomidis I, Papadimitriou C A Currently in press at J Pharm Sciences [January 2010]
2009«Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions» Mountzios Giannis, Bamias Aristotelis, Koutsoukou Vassiliki, Anastasiou Ioannis, Stravodimos Konstantinos, Antoniou Nikolaos, Papadopoulos Georgios, Pavlakis Georgios, Papassavas Pantelis and Dimopoulos Meletios-Athanasios. J Cancer Res Clin Oncol. 2009; 135: 1495-1500
2009«Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid» Giannis Mountzios, Evangelos Terpos, Konstantinos Syrigos, Christos Papadimitriou, Giorgos Papadopoulos, Aristotelis Bamias, Μyron Μavrikakis and Meletios-Athanassios Dimopoulos. J Transl Res 2009 Dec; [Epub ahead of print]
2009«Low frequency of somatic mutations in uterine sarcomas: a molecular analysis and review of the literature» S. Murray, H. Linardou, G. Mountzios, M. Manoloukos, S. Markaki, E. Eleutherakis-Papaiakovou, N. Nikitas, M.-A. Dimopoulos, and C. A. Papadimitriou. Mut Res 2009 Dec; [Epub ahead of print]
2009«Histopathologic and genetic alterations as predictors of response to treatment and survival in lung cancer: A review of published data» Mountzios G, Dimopoulos MA, Soria JC, Sanoudou D, Papadimitriou CA.Crit Rev Oncol Hematol. 2009 Nov 12. [Epub ahead of print]
2009Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study. Mountzios G, Dimopoulos MA, Bamias A, Vourli G, Kalofonos H, Aravantinos G, Fountzilas G, Papadimitriou CA. Ann Oncol. 2009 Aug: 20(8):1362-8
2008«Endocardial metastases as the only site of relapse in a patient with bladder carcinoma: A case report and review of the literature» Mountzios G, Bamias A, Dalianis A, Danias P, Pantelidaki E, Nanas J, Dimopoulos MA. Int J Cardiol. 2008 Nov 29. [Epub ahead of print]
2008«Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer»Mountzios G, Dimopoulos MA, Papadimitriou C.Biomark Insights. 2008 Apr 17;3:219-226
2008«Mechanisms of Disease: signal transduction in lung carcinogenesis: a comparison of smokers and never-smokers»Mountzios G, Fouret P, Soria JC. Nat Clin Pract Oncol. 2008 Oct;5(10):610-8.
2008«Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers»Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P. Clin Cancer Res. 2008 Jul 1;14(13):4096-102.
2008«Aurora kinases as targets for cancer therapy» Mountzios G, Terpos E and Dimopoulos MA. Cancer Treat Rev. 2008 Apr;34(2):175-82.
2008«Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: proposal for a new prognostic model» Mountzios G, Bamias A, Voulgaris Z, Rodolakis A, Vlahos G, Gourgoulis G, Papaiakovou EE, Giannopoulos A. Gynecol Oncol. 2008 Jan;108(1):130-5.
2007“Abnormal bone remodeling process is due to an imbalance in the Receptor Activator of Nuclear Factor–kB Ligand (RANKL)/Osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton. Giannis Mountzios, Meletios-Athanassios Dimopoulos, Aristotelis Bamias, George Papadopoulos, Efstathios Kastritis, Konstantinos Syrigos, George Pavlakis and Evangelos Terpos. 251 General Airforce Hospital, Medical Oncology Dpt and University of Athens School of Medicine, “Alexandra” Hospital, Dpt. of Oncology. Acta Oncol. 2007;46(2):221-9.
2007«ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer» Olaussen KA, Mountzios G and Soria JC. Curr Opin Pulm Med. 2007 Jul;13(4):284-9.
2007«Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma» Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC, Fouret P. Clin Cancer Res. 2007 Jul 1;13(13):3855-9.
2007Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Taillade L, Penault-Llorca F, Boulet T, Fouret P, Michiels S, Taranchon Mountzios G, Validire P, Domont J, Girard P, Grunenwald D, Le Chevalier T, Soria JC. Ann Oncol. 2007 Jun:18(6):1043-50.
2006“Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: A case report and review of the literature” G.Pavlakis, G. Mountzios, , E. Terpos, A. Leivaditou, G. Papadopoulos, P. Papassavas 251 General Airforce Hospital, Medical Oncology Dpt, Athens, Greece.Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:299-303.
2006“Concurrent Development of Testicular Seminoma and Choriocarcinoma of the Superior Mediastinum, Presented as Cervical Mass: A Case Report and Implications about Pathogenetic Mechanisms" Giannis Mountzios, Evangelos Terpos, George Sakorafas, Alexandra Leivaditou,George Papadopoulos, George Pavlakis, Evangelos Syrigos and Meletios-Athanasios Dimopoulos 251 General Airforce Hospital, Medical Oncology Dpt, Athens, Greece. BMC Clin Pathol. 2006 Nov 20;6(1):8
2006“Advanced non-small-cell lung cancer: 'triplets' better than 'doublets'?” Giannis Mountzios and Jean-Charles Soria Institut Gustave Roussy, Dpt of Medicine, Villejuif, France. Nat Clin Pract Oncol. 2006 Sep;3(9):476-7.
 

Συμμετοχή στη συγγραφή Διεθνών Επιστημονικών Συγγραμμάτων

 

Παρακάτω μπορείτε να δείτε τις συμμετοχές του Ιατρού Ι. Μούντζιου στην συγγραφή διεθνών επιστημονικών συγγραμάτων.

TITLEEDITORSAUTHOR OF CHAPTERPUBLISHER
1. «Targeted Therapies in Oncology» Pr. Giuseppe Giaccone and Pr. Jean -Charles Soria. «Overview of existing therapies»Informa Healthcare USA Ó 2007
2. «European Society for Medical Oncology (ESMO) Handbook of Oncological emergencies». Pr. D. Sjivers«Nausea and Vomiting»Taulor and Francis Group Ó 2006
3. «Hellenic Academy of Medical Oncology» Book Series Dr. Briasoulis and Dr. Siamantas.«Chemotherapy for early-stage ovarian cancer» And «Chemotherapy for hormone-refractory prostate cancer»Hellenic Society for Medical Oncology Greece Ó 2007-9
4. Hellenic Society of Medical Oncology publication: «Forum of Clinical Oncology» «Pharmacogenomics and Molecular targeted Therapy» Hellenic Society for Medical Oncology Greece Ó 2008